ADME Toxicology Testing Market Report 2025

The ADME toxicology testing market size has grown rapidly in recent years. It will grow from $10.4 billion in 2024 to $11.53 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to stringent regulatory requirements, rising drug development activities, growing concerns about drug safety, advancements in in vitro testing methods, increased outsourcing of toxicology studies.

The ADME toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $18.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to rapid expansion of biopharmaceuticals, growing emphasis on personalized medicine, emergence of advanced therapies, enhanced predictive toxicology models, global increase in chemical safety testing. Major trends in the forecast period include expansion of biomarker applications, integration of multi-omics data, regulatory emphasis on in vitro testing, collaborations and partnerships, continuous advancements in technology.

The increasing demand for novel drugs is anticipated to drive the growth of the ADME toxicology testing market in the coming years. Novel drugs are pharmaceutical substances that have not been previously approved or marketed for therapeutic purposes. ADME toxicity testing is a crucial phase in drug development to ensure that the novel drug is safe and does not produce harmful toxins in the body. For example, in January 2024, the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a U.S. Food and Drug Administration (FDA) branch, indicated that CDER approved 55 novel drugs in 2023, with 20 (36%) classified as first-in-class, compared to 37 novel drug approvals in 2022. Thus, the rising demand for novel drugs is fueling the growth of the ADME toxicology testing market.

The expanding pharmaceutical industry is expected to drive the growth of the ADME toxicology testing market in the future. The pharmaceutical industry encompasses the discovery, development, and production of drugs and medicines by both government and private entities. This sector employs ADME toxicology testing to assess the absorption, distribution, metabolism, and excretion (ADME) characteristics of drug candidates and evaluate their potential toxicity. Such testing is essential for predicting a drug's behavior within the human body, including its absorption rates, distribution to target tissues, metabolism, and elimination. For instance, in September 2024, statistics from Cross River Therapy, a U.S.-based provider of ABA therapy services, indicated that the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicines in 2021. Projected spending is anticipated to rise to between $605 billion and $635 billion by 2025. Therefore, the growth of the pharmaceutical industry is driving the expansion of the ADME toxicology testing market.

Technological advancements are emerging as a pivotal trend gaining traction within the ADME toxicology testing market. Major companies within this sector are actively introducing innovative assay solutions embedded with advanced technologies, aiming to fortify their market standing. An illustrative example occurred in April 2022 when Charles River Laboratories International Inc., a US-based pharmaceutical company, partnered with Valo Health Inc., a US-based AI-health solutions provider, to unveil Logica. This cutting-edge AI-based drug development solution harnesses Valo’s Opal Computational Platform, utilizing AI to offer ADME toxicology testing services and other drug delivery solutions, thereby revolutionizing drug development methodologies.

Prominent entities operating within the ADME toxicology testing market are integrating advanced technologies such as Cyprotex e-Store, fostering a seamless avenue for online ordering of ADME-Tox services. ADME-Tox services serve the purpose of reducing development costs and time, mitigating the risk of failure in later stages, and facilitating the identification of optimal candidates for clinical development. For instance, in October 2023, Evotec SE, a Germany-based biotechnology company, launched the Cyprotex e-Store, an e-commerce platform designed to provide convenient online access to the company's comprehensive range of ADME-Tox services. This platform streamlines and expedites the purchasing process, enabling registered users to assess and order Cyprotex' offerings at any time, seven days a week. The e-Store grants instant access to pricing details and comprehensive protocols online, allowing users to easily place, track, and reorder services as needed. This efficient platform significantly reduces service lead times, ensuring users receive their data promptly, thus enhancing overall efficiency in ADME-Tox testing processes.

In September 2022, BioIVT, a U.S.-based provider of drug development solutions, successfully acquired XenoTech for an undisclosed amount. This strategic acquisition marks a significant milestone for BioIVT, as it not only complements and strengthens its existing product portfolio but also facilitates the expansion of its offerings into new geographical regions and a wider customer base. XenoTech, a U.S.-based contract research organization, specializes in providing ADME-toxicology testing services. The acquisition underscores BioIVT's commitment to enhancing its capabilities and presence in the field of drug development.

Major companies operating in the ADME toxicology testing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

North America was the largest region in the ADME toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the adme toxicology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

ADME toxicology testing comprises a series of studies aimed at evaluating the potential toxicity of a substance or drug candidate based on its absorption, distribution, metabolism, and excretion (ADME) properties. These tests play a crucial role in drug development, ensuring the safety and well-being of individuals exposed to various substances.

The primary products associated with ADME toxicology testing include instruments, software solutions, assay systems, reagents, and other related items. Instruments are specialized devices or tools designed for specific purposes, commonly utilized in scientific, medical, or technical contexts. In the context of ADME toxicity testing, instruments are used for the measurement and analysis of readings. Various methods are employed in ADME toxicology testing, including cellular assay, biochemical assay, in silico, and ex-vivo approaches. These methods are complemented by technologies such as single-cell culture, high throughput screening, molecular imaging, omics technology, and other relevant technologies. ADME toxicology testing is applied to assess systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other factors. Industries that benefit from these tests include cosmetics and household products, pharmaceuticals, the animal industry, the food industry, and others.

The ADME toxicology testing market research report is one of a series of new reports that provides ADME toxicology testing market statistics, including ADME toxicology testing industry global market size, regional shares, competitors with an ADME toxicology testing market share, detailed ADME toxicology testing market segments, market trends and opportunities, and any further data you may need to thrive in the ADME toxicology testing industry. This ADME toxicology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ADME toxicology testing market consists of revenues earned by entities by providing services such as drug discovery research, measuring gene expression, and preclinical efficacy testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The ADME toxicology testing market also includes sales of ADMET predictors, and UV spectrophotometers, which are used in providing ADME toxicology testing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.